(redirected from Incretins)
Also found in: Medical.
Related to Incretins: glucagon


Any of several gastrointestinal hormones that bring about the release of insulin from the pancreas after carbohydrate ingestion and are essential in maintaining normal levels of glucose in the blood.

[Blend of increase and secretin.]
Mentioned in ?
References in periodicals archive ?
Incretins are the superfamily of polypeptides released from intestinal cells in response to nutritional ingestion.
Incretins are gastrointestinal hormones that increase insulin release from beta cells in the pancreas, while also inhibiting glucagon secretion and slowing absorption of carbohydrates.
But the risk of cancer diminished over time, suggesting that there was no causal relationship between incretins and pancreatic cancer.
That's where the incretins come into play, he said.
In response to the review article by Gupta, "Pleiotropic effects of incretins," we conducted a small prospective study to see benefits with injectable incretin liraglutide.
1] Some of these new therapeutic agents, the incretins, have been shown to lower traditional cardiovascular risk factors and also mitigate newly identified risk factors such as hypoglycaemia and weight gain, both of which often develop as adverse effects when tight glucose control is achieved.
A new class of antidiabetics allow the natural intestinal insulin controllers, called incretins, to stay longer.
The American Diabetes Association/European Association for the Study of Diabetes consensus algorithm for the treatment of type 2 DM endorses the use of newer class of drugs, the incretins or incretin-based therapies such as DPP-4 inhibitors, either alone or in combination.
After a meal, your body produces incretins, hormones that lower sugar levels.
Medications such as exenatide (Byetta) are called incretin mimetics, because they mimic incretins, which are hormones released into the blood when we digest food.
6 These incretins play a role in glucose homeostasis by increasing insulin release in response to a meal; GLP1 also decreases glucagon release.
Their insulin-regulating role, dubbed the "incretin effect," has led to development of synthetic incretins now used in treatment of type 2 diabetes.